Contrast-Free Magnetic Resonance Imaging for Breast Disease

Launched by PERSPECTUM · Aug 6, 2021

Keywords

ClinConnect Summary

This clinical trial is looking into a new way to check for breast diseases, including breast cancer, using a type of MRI that doesn't require any contrast dye. The study aims to see how well this new method works for women who are either at risk for breast cancer or have signs that may suggest they have breast issues. It's currently recruiting participants, and it's specifically for women aged 30 and older who have been referred to a breast screening clinic.

To participate, women must be in good health and willing to give their consent to join the study. However, certain conditions, like having a pacemaker, severe anxiety in tight spaces, or other significant health issues, may prevent someone from taking part. Those who join can expect to undergo a non-invasive MRI scan, which is generally safe and does not involve needles or injections. This study is important because it may help improve how doctors diagnose breast diseases, making the process simpler and safer for patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female 30 years of age and over
• • Participant has been referred to a secondary care breast screening clinic.
• • Participant is willing and able to give informed consent for participation in the investigation.
• • Exclusion Criteria
• • The participant may not enter the study with any known contraindication to magnetic resonance imaging (including but not limited to a pacemaker or other metallic unfixed implanted device, metallic fragments, extensive tattoos, severe claustrophobia).
• • Any other cause, including a significant underlying disease or disorder which, in the opinion of the investigator, may put the participant at risk by participating in the study or limit the participant's ability to participate.